← FDA Drug Approvals (Drugs@FDA)

OXACILLIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WOCKHARDT BIO AG · Approved 2017-11-24

Drug application

FDA Application #

ANDA207148

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXACILLIN SODIUM

Generic name

OXACILLIN

Active ingredients

OXACILLIN SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

WOCKHARDT BIO AG

Manufacturer

Wockhardt USA LLC.

First approval

2017-11-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown